Generic drug of the therapeutic class: Dermatology
active ingredients: Flumetasone, salicylic acid
15 g tube
Corticosensitive dermatoses with keratotic or squamous component:
- psoriasis excluding psoriasis in large plates,
- lichen plan,
- palmoplantar keratoderma.
The ointment form is more particularly intended for dry or scaly lesions .
Dosage ALKOSALEN 0.02% / 3% Ointment 15 g tube
Treatment should be limited to 2 applications per day for 2 weeks then 1 time per day.
The duration of the treatment will not exceed 4 weeks.
An increase in the number of daily applications could aggravate the adverse effects without improving the therapeutic effects.
The treatment of large areas requires monitoring of the number of tubes used.
It is advisable to apply the product in spaced keys, then to spread it while massaging slightly until it is entirely absorbed.
Some dermatoses make it desirable to stop gradually. It can be obtained by reducing the frequency of applications and / or by the use of a less strong or less dosed corticosteroid.
- hypersensitivity to any of the products contained in the preparation, in particular salicylates or a related substance,
- primitive bacterial, viral, fungal or parasitic infections,
- application on the eyelids (risk of glaucoma).
Do not apply to the breasts during breastfeeding, because of the risk of ingestion of the product by the newborn.
Alkosalen side effects
- Prolonged use of corticosteroids of moderate activity may cause skin atrophy, telangiectasia (to be particularly feared on the face), stretch marks (at the root of the limbs in particular, and occurring more readily in adolescents), an ecchymotic purpura secondary to atrophy, skin fragility.
- In the face, corticosteroids can create peri-oral dermatitis or aggravate rosacea (see warnings and contraindications).
- It may be observed a delay of healing of unstressed wounds, pressure ulcers, leg ulcers (see contraindications).
- Possibility of systemic effects (see warnings: cushingoid syndrome, slowing of growth, acute adrenal insufficiency).
- Acneiform or pustular eruptions, hypertrichosis, depigmentations have been reported.
- Secondary infections, especially under occlusive dressing or in folds and allergic contact dermatoses have also been reported during the use of local corticosteroids.